dalantercept
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for dalantercept, covering 2016-02-05 to 2021-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma [Phase 2]